Pharmaceuticals

Roxadustat Market Size and Demand Forecast 2026–2030

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the roxadustat market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Roxadustat Market between 2026 and 2030?

The roxadustat market has experienced robust expansion over recent years. It is anticipated to expand from $6.86 billion in 2025 to $7.33 billion in 2026, showing a compound annual growth rate (CAGR) of 6.9%. This historical growth can be attributed to several factors including the significant occurrence of chronic kidney disease, the reliance on erythropoiesis-stimulating agents, anemia management predominantly in hospitals, the limited availability of oral anemia treatments, and the increasing number of dialysis centers.

The roxadustat market is anticipated to experience substantial growth in the upcoming years, projected to reach $9.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This expansion during the forecast period is attributed to the increasing global burden of anemia, a rising preference for oral therapeutic options, the expanding population of patients with chronic kidney disease (CKD), the growth in outpatient anemia management, and improved access to innovative anemia drugs. Key trends identified for the forecast period include the increasing adoption of oral anemia therapies, a growing use of HIF-PHI drugs, a heightened focus on CKD-associated anemia, a shift away from injectable erythropoiesis-stimulating agents (ESAs), and an overall expansion in the accessibility of anemia treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21280&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Roxadustat Market?

An increasing prevalence of chronic kidney disease (CKD) is anticipated to drive the expansion of the Roxadustat market in the future. CKD represents a persistent ailment characterized by a progressive decline in kidney function, frequently culminating in renal failure if not addressed. Globally, the population afflicted by chronic kidney disease is expanding, attributed to elements like an aging demographic, escalating incidences of diabetes and high blood pressure, and detrimental lifestyle choices. Roxadustat aids in managing CKD through the stimulation of erythropoietin synthesis, consequently boosting red blood cell generation and mitigating anemia, a frequent complication of the disease, ultimately enhancing renal function and patient quality of life. As an illustration, data from June 2023 provided by Kidney Research UK, a charity based in the UK, projects that by 2033, the count of individuals in CKD stages 3–5 will likely reach 3.9 million. Consequently, the growing population affected by chronic kidney disease (CKD) is a key impetus for the expansion of the Roxadustat market.

What Segments Are Included Within The Roxadustat Market?

The roxadustat market covered in this report is segmented –

1) By Type: 20mg, 50mg

2) By Product Formulation: Oral Tablets

3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers

4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions

Which Trends Are Shaping Activity Within The Roxadustat Market?

Leading companies within the roxadustat market are focused on accumulating real-world evidence, such as observational registry studies, to bolster the long-term value, safety, and usage patterns of their HIF PH inhibitor therapy. Real-world evidence refers to clinical data gathered outside of controlled trials, in typical practice environments, to reflect actual patient experiences. The roxadustat market facilitates this trend by funding large-scale real-world studies, which healthcare payers and regulators are increasingly relying on for their evaluations. As an example, in May 2024, Astellas Pharma, a UK based company, finalized the initiation of the WINE study through the WiNe Registry in Germany, which is a non-interventional cohort study documenting clinical outcomes, dosing characteristics, and hemoglobin response in patients treated with EVRENZO (roxadustat). The insights obtained from that registry assist in demonstrating roxadustat’s efficacy in real-world CKD populations and support long-term reimbursement choices. Thus, the production of real-world evidence is propelling the expansion of the roxadustat market.

Who Are The Core Companies Influencing Trends In The Roxadustat Market?

Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy’s Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/roxadustat-global-market-report

Which Regions Are Projected To Dominate The Roxadustat Market In The Coming Years?

North America was the largest region in the Roxadustat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roxadustat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Roxadustat Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21280&type=smp

Browse Through More Reports Similar to the Global Roxadustat Market 2026, By The Business Research Company

Rotavators Market Report 2026

https://www.thebusinessresearchcompany.com/report/rotavators-global-market-report

Vermiculite Market Report 2026

https://www.thebusinessresearchcompany.com/report/vermiculite-global-market-report

Agritech Market Report 2026

https://www.thebusinessresearchcompany.com/report/agritech-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795